David Bryant
Impact in
-
- Renal cell carcinoma treatment
- Lung Cancer Treatments and Mutations
- Inhalation and Respiratory Drug Delivery
-
- Cancer Genomics and Diagnostics
Papers in
-
- Respiratory and Cough-Related Research 5
- Renal cell carcinoma treatment 3
- Oncology 5
- Co-authors
- Jaclyn Y. Hung (1 shared paper)Carmen Behrens (1 shared paper)John D. Minna (1 shared paper)Ignacio I. Wistuba (1 shared paper)Sara Milchgrub (1 shared paper)Adi F. Gazdar (1 shared paper)Zoran Gatalica (5 shared papers)Nicholas J. Vogelzang (5 shared papers)
- Journals
- Journal of Clinical Oncology (7 papers)The Medical Journal of Australia (7 papers)CHEST Journal (3 papers)Neuro-Oncology (1 paper)Addictive Behaviors (1 paper)
- Partner nations
- United StatesAustraliaBosnia and Herzegovina
In The Last Decade
David Bryant
27 papers receiving 711 citations
Peers
Comparison fields: 5 of 86
- Pulmonary and Respiratory Medicine 313
- Cancer Research 121
- Chemical Health and Safety 5
- Oncology 152
- Physiology 101
Countries citing papers authored by David Bryant
This map shows the geographic impact of David Bryant's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Bryant with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Bryant more than expected).
Fields of papers citing papers by David Bryant
This network shows the impact of papers produced by David Bryant. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Bryant. The network helps show where David Bryant may publish in the future.
Co-authors
The 25 scholars most cited alongside David Bryant, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 27 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1999 | 251 | |
| 2 | 2015 | 131 | |
| 3 | 1985 | 68 | |
| 4 | 2014 | 54 | |
| 5 | 2015 | 50 | |
| 6 | 2018 | 40 | |
| 7 | 1995 | 32 | |
| 8 | 1992 | 21 | |
| 9 | 1991 | 16 | |
| 10 | 1991 | 11 | |
| 11 | 1989 | 8 | |
| 12 | 1992 | 7 | |
| 13 | 1983 | 7 | |
| 14 | 1988 | 6 | |
| 15 | 2013 | 6 | |
| 16 | 1991 | 6 | |
| 17 | 2023 | 3 | |
| 18 | 1973 | 3 | |
| 19 | 1988 | 3 | |
| 20 | 2015 | 3 |
About David Bryant
David Bryant is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Physiology, Cancer Research and Surgery, having authored 27 papers that have together received 735 indexed citations. Recurring topics across this work include Asthma and respiratory diseases (5 papers), Respiratory and Cough-Related Research (5 papers), Cancer Genomics and Diagnostics (4 papers), Renal cell carcinoma treatment (3 papers), Bladder and Urothelial Cancer Treatments (3 papers), Pharmacological Effects and Assays (2 papers), Pneumocystis jirovecii pneumonia detection and treatment (2 papers) and Occupational exposure and asthma (2 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (313 citations), Cancer Research (121 citations), Chemical Health and Safety (5 citations), Oncology (152 citations) and Physiology (101 citations). David Bryant has collaborated with scholars based in United States, Australia and Bosnia and Herzegovina. Frequent co-authors include Jaclyn Y. Hung, Carmen Behrens, John D. Minna, Ignacio I. Wistuba, Sara Milchgrub, Adi F. Gazdar, Zoran Gatalica, Nicholas J. Vogelzang, Sherri Z. Millis and Peter A. W. Rogers. Their work appears in journals such as Journal of Clinical Oncology, The Medical Journal of Australia, CHEST Journal, Neuro-Oncology and Addictive Behaviors.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.